Global Dexlansoprazole API Market Research Report 2024

Publication ID:

PB505247900

Publication Date:

May 22, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

Dexlansoprazole is used to heal and maintain healing of听erosive esophagitis听and to treat听heartburn听associated with听gastroesophageal reflux disease听(GERD).听It lasts longer than听lansoprazole, to which it is chemically related, and needs to be taken less often.听There is no good evidence that it works better than other PPIs.
The global Dexlansoprazole API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Dexlansoprazole API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dexlansoprazole API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Dexlansoprazole API include Piramal Enterprises Limited, Metrochem API Private Limited, Zhejiang Hengkang Pharmaceutical, Lupin Ltd, Dipharma, Optimus Pharma P Limited and Orchid Chemicals & Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Dexlansoprazole API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dexlansoprazole API.
Report Scope
The Dexlansoprazole API market size, estimations, and forecasts are provided in terms of output/shipments (Ton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dexlansoprazole API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dexlansoprazole API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Piramal Enterprises Limited
Metrochem API Private Limited
Zhejiang Hengkang Pharmaceutical
Lupin Ltd
Dipharma
Optimus Pharma P Limited
Orchid Chemicals & Pharmaceuticals
Segment by Type
笔耻谤颈迟测鈮�98%
Purity<98%
Segment by Application
Dexlansoprazole Capsules
Others
Production by Region
Europe
China
China Taiwan
India
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dexlansoprazole API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Dexlansoprazole API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Dexlansoprazole API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Dexlansoprazole API Market Overview
1.1 Product Definition
1.2 Dexlansoprazole API Segment by Type
1.2.1 Global Dexlansoprazole API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 笔耻谤颈迟测鈮�98%
1.2.3 Purity<98%
1.3 Dexlansoprazole API Segment by Application
1.3.1 Global Dexlansoprazole API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Dexlansoprazole Capsules
1.3.3 Others
1.4 Global Market Growth Prospects
1.4.1 Global Dexlansoprazole API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Dexlansoprazole API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Dexlansoprazole API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Dexlansoprazole API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Dexlansoprazole API Production Market Share by Manufacturers (2019-2024)
2.2 Global Dexlansoprazole API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Dexlansoprazole API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Dexlansoprazole API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Dexlansoprazole API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Dexlansoprazole API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Dexlansoprazole API, Product Offered and Application
2.8 Global Key Manufacturers of Dexlansoprazole API, Date of Enter into This Industry
2.9 Dexlansoprazole API Market Competitive Situation and Trends
2.9.1 Dexlansoprazole API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Dexlansoprazole API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Dexlansoprazole API Production by Region
3.1 Global Dexlansoprazole API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Dexlansoprazole API Production Value by Region (2019-2030)
3.2.1 Global Dexlansoprazole API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Dexlansoprazole API by Region (2025-2030)
3.3 Global Dexlansoprazole API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Dexlansoprazole API Production by Region (2019-2030)
3.4.1 Global Dexlansoprazole API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Dexlansoprazole API by Region (2025-2030)
3.5 Global Dexlansoprazole API Market Price Analysis by Region (2019-2024)
3.6 Global Dexlansoprazole API Production and Value, Year-over-Year Growth
3.6.1 Europe Dexlansoprazole API Production Value Estimates and Forecasts (2019-2030)
3.6.2 China Dexlansoprazole API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Taiwan Dexlansoprazole API Production Value Estimates and Forecasts (2019-2030)
3.6.4 India Dexlansoprazole API Production Value Estimates and Forecasts (2019-2030)
4 Dexlansoprazole API Consumption by Region
4.1 Global Dexlansoprazole API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Dexlansoprazole API Consumption by Region (2019-2030)
4.2.1 Global Dexlansoprazole API Consumption by Region (2019-2024)
4.2.2 Global Dexlansoprazole API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Dexlansoprazole API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Dexlansoprazole API Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Dexlansoprazole API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Dexlansoprazole API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Dexlansoprazole API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Dexlansoprazole API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Dexlansoprazole API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Dexlansoprazole API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Dexlansoprazole API Production by Type (2019-2030)
5.1.1 Global Dexlansoprazole API Production by Type (2019-2024)
5.1.2 Global Dexlansoprazole API Production by Type (2025-2030)
5.1.3 Global Dexlansoprazole API Production Market Share by Type (2019-2030)
5.2 Global Dexlansoprazole API Production Value by Type (2019-2030)
5.2.1 Global Dexlansoprazole API Production Value by Type (2019-2024)
5.2.2 Global Dexlansoprazole API Production Value by Type (2025-2030)
5.2.3 Global Dexlansoprazole API Production Value Market Share by Type (2019-2030)
5.3 Global Dexlansoprazole API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Dexlansoprazole API Production by Application (2019-2030)
6.1.1 Global Dexlansoprazole API Production by Application (2019-2024)
6.1.2 Global Dexlansoprazole API Production by Application (2025-2030)
6.1.3 Global Dexlansoprazole API Production Market Share by Application (2019-2030)
6.2 Global Dexlansoprazole API Production Value by Application (2019-2030)
6.2.1 Global Dexlansoprazole API Production Value by Application (2019-2024)
6.2.2 Global Dexlansoprazole API Production Value by Application (2025-2030)
6.2.3 Global Dexlansoprazole API Production Value Market Share by Application (2019-2030)
6.3 Global Dexlansoprazole API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Piramal Enterprises Limited
7.1.1 Piramal Enterprises Limited Dexlansoprazole API Corporation Information
7.1.2 Piramal Enterprises Limited Dexlansoprazole API Product Portfolio
7.1.3 Piramal Enterprises Limited Dexlansoprazole API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Piramal Enterprises Limited Main Business and Markets Served
7.1.5 Piramal Enterprises Limited Recent Developments/Updates
7.2 Metrochem API Private Limited
7.2.1 Metrochem API Private Limited Dexlansoprazole API Corporation Information
7.2.2 Metrochem API Private Limited Dexlansoprazole API Product Portfolio
7.2.3 Metrochem API Private Limited Dexlansoprazole API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Metrochem API Private Limited Main Business and Markets Served
7.2.5 Metrochem API Private Limited Recent Developments/Updates
7.3 Zhejiang Hengkang Pharmaceutical
7.3.1 Zhejiang Hengkang Pharmaceutical Dexlansoprazole API Corporation Information
7.3.2 Zhejiang Hengkang Pharmaceutical Dexlansoprazole API Product Portfolio
7.3.3 Zhejiang Hengkang Pharmaceutical Dexlansoprazole API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Zhejiang Hengkang Pharmaceutical Main Business and Markets Served
7.3.5 Zhejiang Hengkang Pharmaceutical Recent Developments/Updates
7.4 Lupin Ltd
7.4.1 Lupin Ltd Dexlansoprazole API Corporation Information
7.4.2 Lupin Ltd Dexlansoprazole API Product Portfolio
7.4.3 Lupin Ltd Dexlansoprazole API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Lupin Ltd Main Business and Markets Served
7.4.5 Lupin Ltd Recent Developments/Updates
7.5 Dipharma
7.5.1 Dipharma Dexlansoprazole API Corporation Information
7.5.2 Dipharma Dexlansoprazole API Product Portfolio
7.5.3 Dipharma Dexlansoprazole API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Dipharma Main Business and Markets Served
7.5.5 Dipharma Recent Developments/Updates
7.6 Optimus Pharma P Limited
7.6.1 Optimus Pharma P Limited Dexlansoprazole API Corporation Information
7.6.2 Optimus Pharma P Limited Dexlansoprazole API Product Portfolio
7.6.3 Optimus Pharma P Limited Dexlansoprazole API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Optimus Pharma P Limited Main Business and Markets Served
7.6.5 Optimus Pharma P Limited Recent Developments/Updates
7.7 Orchid Chemicals & Pharmaceuticals
7.7.1 Orchid Chemicals & Pharmaceuticals Dexlansoprazole API Corporation Information
7.7.2 Orchid Chemicals & Pharmaceuticals Dexlansoprazole API Product Portfolio
7.7.3 Orchid Chemicals & Pharmaceuticals Dexlansoprazole API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Orchid Chemicals & Pharmaceuticals Main Business and Markets Served
7.7.5 Orchid Chemicals & Pharmaceuticals Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Dexlansoprazole API Industry Chain Analysis
8.2 Dexlansoprazole API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Dexlansoprazole API Production Mode & Process
8.4 Dexlansoprazole API Sales and Marketing
8.4.1 Dexlansoprazole API Sales Channels
8.4.2 Dexlansoprazole API Distributors
8.5 Dexlansoprazole API Customers
9 Dexlansoprazole API Market Dynamics
9.1 Dexlansoprazole API Industry Trends
9.2 Dexlansoprazole API Market Drivers
9.3 Dexlansoprazole API Market Challenges
9.4 Dexlansoprazole API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

Piramal Enterprises Limited
Metrochem API Private Limited
Zhejiang Hengkang Pharmaceutical
Lupin Ltd
Dipharma
Optimus Pharma P Limited
Orchid Chemicals & Pharmaceuticals

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂